AI-generated summary
The authors report a double-blind, self-controlled trial in which 53 head and neck cancer patients had one oral mucositis lesion treated with photobiomodulation and another given sham treatment. Photobiomodulation was associated with significantly lower pain and lesion severity scores and more complete healing than sham. The authors describe these findings as supporting a possible supportive care role.
- Participants
- 53
- Who or what was studied
- Patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy who developed radiation-induced oral mucositis; 163 were screened and 53 were analyzed
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe a limitation explicitly; the analysis used one comparison lesion per patient and reports a predictive factor from a multivariable model without further detail on sample size constraints.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 150 mW
- Total energy
- 5 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Oral mucositis, Photobiomodulation, Visual analogue scale, Low-level laser therapy, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.